Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksander Krag

Showing results (81-90 of 326) with videos related to

Pageof 33
Sort By:
The Lancet. Gastroenterology & Hepatology|August 11, 2023
MetALD: new opportunities to understand the role of alcohol in steatotic liver diseaseMads Israelsen, Nikolaj Torp, Stine Johansen, et al.
The Lancet. Gastroenterology & Hepatology|June 10, 2023
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease - Authors' replyMads Israelsen, Nikolaj Torp, Stine Johansen, et al.
Annals of Hepatology|October 11, 2025
Limitations of MELD and MELD 3.0 for prognostication in patients with cirrhosis hospitalized with acute decompensation: an analysis of the ATTIRE trialNikolaj Torp, Nick Freemantle, Mads Israelsen, et al.
BMJ Open|August 16, 2013
Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysisMaja Thiele, Lise L Gluud, Emilie K Dahl, et al.
European Journal of Gastroenterology & Hepatology|March 24, 2012
High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosisChristian Mortensen, Ove Andersen, Aleksander Krag, et al.
BMJ Open|October 24, 2012
Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trialsNina Kimer, Emilie Kristine Dahl, Lise Lotte Gluud, et al.
Gut|May 20, 2016
Sequential shear-wave elastography of liver and spleen rules out clinically significant portal hypertension in compensated advanced chronic liver diseaseChristian Jansen, Christopher Bogs, Aleksander Krag, et al.
Molecular Biology Reports|June 9, 2026
Multiplexed targeted mRNA profiling of alcohol-related liver disease reveals stage-specific dysregulation of signaling pathwaysDusan Rasic, Maja Thiele, Peter Andersen, et al.
Journal of Hepatology|February 5, 2016
Keep the sick from harm in spontaneous bacterial peritonitis: Dose of beta blockers mattersBjørn Stæhr Madsen, Kristina Fruerlund Nielsen, Annette Dam Fialla, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 28, 2006
Effect of meal and propranolol on whole body and splanchnic oxygen consumption in patients with cirrhosisAleksander Krag, Lene Simonsen, Jens H Henriksen, et al.
Pageof 33

Showing results (81-90 of 326) with videos related to

Sort By:
Pageof 33
The Lancet. Gastroenterology & Hepatology|August 11, 2023
MetALD: new opportunities to understand the role of alcohol in steatotic liver diseaseMads Israelsen, Nikolaj Torp, Stine Johansen, et al.
The Lancet. Gastroenterology & Hepatology|June 10, 2023
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease - Authors' replyMads Israelsen, Nikolaj Torp, Stine Johansen, et al.
Annals of Hepatology|October 11, 2025
Limitations of MELD and MELD 3.0 for prognostication in patients with cirrhosis hospitalized with acute decompensation: an analysis of the ATTIRE trialNikolaj Torp, Nick Freemantle, Mads Israelsen, et al.
BMJ Open|August 16, 2013
Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysisMaja Thiele, Lise L Gluud, Emilie K Dahl, et al.
European Journal of Gastroenterology & Hepatology|March 24, 2012
High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosisChristian Mortensen, Ove Andersen, Aleksander Krag, et al.
BMJ Open|October 24, 2012
Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trialsNina Kimer, Emilie Kristine Dahl, Lise Lotte Gluud, et al.
Gut|May 20, 2016
Sequential shear-wave elastography of liver and spleen rules out clinically significant portal hypertension in compensated advanced chronic liver diseaseChristian Jansen, Christopher Bogs, Aleksander Krag, et al.
Molecular Biology Reports|June 9, 2026
Multiplexed targeted mRNA profiling of alcohol-related liver disease reveals stage-specific dysregulation of signaling pathwaysDusan Rasic, Maja Thiele, Peter Andersen, et al.
Journal of Hepatology|February 5, 2016
Keep the sick from harm in spontaneous bacterial peritonitis: Dose of beta blockers mattersBjørn Stæhr Madsen, Kristina Fruerlund Nielsen, Annette Dam Fialla, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 28, 2006
Effect of meal and propranolol on whole body and splanchnic oxygen consumption in patients with cirrhosisAleksander Krag, Lene Simonsen, Jens H Henriksen, et al.
Pageof 33